CoChat

In situ tumour arrays reveal early environmental control of cancer immunity

Ortiz-Muñoz, Guadalupe, Brown, Markus, Carbone, Catherine B., Pechuan-Jorge, Ximo, Rouilly, Vincent, Lindberg, Henrik, Ritter, Alex T., Raghupathi, Gautham, Sun, Qianbo, Nicotra, Tess, Mantri, Shreya R., Yang, Angela, Doerr, Jonas, Nagarkar, Deepti, Darmanis, Spyros, Haley, Benjamin, Mariathasan, Sanjeev, Wang, Yulei, Gomez-Roca, Carlos, de Andrea, Carlos Eduardo, Spigel, David, Wu, Thomas, Delamarre, Lelia, Schöneberg, Johannes, Modrusan, Zora, Price, Richard, Turley, Shannon J., Mellman, Ira, Moussion, Christine · 2023 · Nature
Cited by 53

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The immune phenotype of a tumour is a key predictor of its response to immunotherapy 1–4. Patients who respond to checkpoint blockade generally present with immune-inflamed 5–7 tumours that are highly infiltrated by T cells. However, not all inflamed tumours respond to therapy, and even lower response rates occur among tumours that lack T cells (immune desert) or that spatially exclude T cells to the periphery of the tumour lesion (immune excluded)8. Despite the importance of these tumour immune phenotypes in patients, little is known about their development, heterogeneity or dynamics owing to the technical difficulty of tracking these features in situ. Here we introduce skin tumour array by microporation (STAMP)—a preclinical approach that combines high-throughput time-lapse imaging with next-generation sequencing of tumour arrays. Using STAMP, we followed the development of thousands of arrayed tumours in vivo to show that tumour immune phenotypes and outcomes vary between adjacent tumours and are controlled by local factors within the tumour microenvironment. Particularly, the recruitment of T cells by fibroblasts and monocytes into the tumour core was supportive of T cell cytotoxic activity and tumour rejection. Tumour immune phenotypes were dynamic over time and an early conversion to an immune-inflamed phenotype was predictive of spontaneous or therapy-induced tumour rejection. Thus, STAMP captures the dynamic relationships of the spatial, cellular and molecular components of tumour rejection and has the potential to translate therapeutic concepts into successful clinical strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06132-2

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 34

  1. Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer–immune set point. Nature 541, 321–330 (2017). · DOI · Paper page
  2. Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197–218 (2019). · DOI · Paper page
  3. Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006). · DOI · Paper page
  4. Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014). · DOI · Paper page
  5. Herbst, R. S. et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515, 563–567 (2014). · DOI · Paper page
  6. Gajewski, T. F. The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment. Semin. Oncol. 42, 663–671 (2015). · DOI · Paper page
  7. Bachhav, Y. G., Heinrich, A. & Kalia, Y. N. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology. Eur. J. Pharm. Biopharm. 84, 355–364 (2013). · DOI
  8. Chung, W.-J. et al. Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous. Proc. Natl Acad. Sci. USA 114, E10947–E10955 (2017).
  9. Mariathasan, S. et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544–548 (2018). · DOI · Paper page
  10. Desbois, M. et al. Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer. Nat. Commun. 11, 5583 (2020). · DOI · Paper page
  11. Spranger, S. & Gajewski, T. F. Impact of oncogenic pathways on evasion of antitumour immune responses. Nat. Rev. Cancer 18, 139–147 (2018). · DOI · Paper page
  12. Liu, X. & Peng, G. Mitochondria orchestrate T cell fate and function. Nat. Immunol. 22, 276–278 (2021). · DOI
  13. Buck, M. D. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166, 63–76 (2016). · DOI · Paper page
  14. Li, W. & Zhang, L. Rewiring mitochondrial metabolism for CD8+ T cell memory formation and effective cancer immunotherapy. Front. Immunol. 11, 1834 (2020). · DOI
  15. Araki, K. et al. Translation is actively regulated during the differentiation of CD8+ effector T cells. Nat. Immunol. 18, 1046–1057 (2017). · DOI · Paper page
  16. Chen, T.-W. et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 499, 295–300 (2013). · DOI · Paper page
  17. Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021). · DOI · Paper page
  18. Tavernari, D. et al. Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression. Cancer Discov. 11, 1490–1507 (2021). · DOI
  19. Angelova, M. et al. Evolution of metastases in space and time under immune selection. Cell 175, 751–765 (2018). · DOI · Paper page
  20. Doerr, J. et al. Whole-brain 3D mapping of human neural transplant innervation. Nat. Commun. 8, 14162 (2017). · DOI
  21. Geraldo, S., Simon, A. & Vignjevic, D. M. Revealing the cytoskeletal organization of invasive cancer cells in 3D. J. Vis. Exp. https://doi.org/10.3791/50763 (2013). · doi:10.3791/50763
  22. Helou, S. M. et al. A relationship-based approach to improving clinical trials: the imCORE research network experience. Contemp. Clin. Trials 86, 105861 (2019). · doi:10.1016/j.cct.2019.105861
  23. Powles, T. et al. Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nat. Med. 25, 1706–1714 (2019). · DOI · Paper page
  24. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009). · DOI · Paper page
  25. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491–498 (2011). · DOI · Paper page
  26. Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs. Bioinformatics 28, 1811–1817 (2012). · DOI · Paper page
  27. Huber, W. et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12, 115–121 (2015). · DOI · Paper page
  28. Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, gky955 (2018).
  29. Fontes, M. & Soneson, C. The projection score—an evaluation criterion for variable subset selection in PCA visualization. BMC Bioinform. 12, 307 (2011). · DOI
  30. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
  31. Liberzon, A. et al. The Molecular Signatures Database hallmark gene set collection. Cell Syst. 1, 417–425 (2015). · DOI · Paper page
  32. Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018). · DOI · Paper page
  33. Henningsson, R., Moratorio, G., Bordería, A. V., Vignuzzi, M. & Fontes, M. DISSEQT—distribution-based modeling of SEQuence space time dynamics. Virus Evol. 5, vez028 (2019). · DOI
  34. Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016). · DOI · Paper page

Cited by

See all 53

Metadata

Authors
Ortiz-Muñoz, G., Brown, M., Carbone, C. B., Pechuan-Jorge, X., Rouilly, V., Lindberg, H., Ritter, A. T., Raghupathi, G., Sun, Q., Nicotra, T., Mantri, S. R., Yang, A., Doerr, J., Nagarkar, D., Darmanis, S., Haley, B., Mariathasan, S., Wang, Y., Gomez-Roca, C., de Andrea, C. E., Spigel, D., Wu, T., Delamarre, L., Schöneberg, J., Modrusan, Z., Price, R., Turley, S. J., Mellman, I., & Moussion, C.
Venue
Nature
Published
2023-05-31
Volume
618
Issue
7966
Pages
827-833
ISSN
  • 0028-0836
  • 1476-4687
Cited by
53
References
8
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In situ tumour arrays reveal early environmental control of cancer immunity. https://app.cochat.ai/papers/10.1038/s41586-023-06132-2
The paper
Ortiz-Muñoz, G., Brown, M., Carbone, C. B., Pechuan-Jorge, X., Rouilly, V., Lindberg, H., Ritter, A. T., Raghupathi, G., Sun, Q., Nicotra, T., Mantri, S. R., Yang, A., Doerr, J., Nagarkar, D., Darmanis, S., Haley, B., Mariathasan, S., Wang, Y., Gomez-Roca, C., . . . Moussion, C. (2023). In situ tumour arrays reveal early environmental control of cancer immunity. Nature. https://doi.org/10.1038/s41586-023-06132-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.